Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Generic Oncology Drugs Industry?

In recent times, the market size for generic oncology drugs has seen robust growth. Projections indicate an advancement from $27.24 billion in 2024 to $28.75 billion in 2025, with a compound annual growth rate (CAGR) of 5.5%. Factors such as patent expirations, control of healthcare costs, rising cancer cases, healthcare insurance coverage, and physician prescription habits have contributed to growth during the historic period.

In the coming years, a robust expansion is anticipated for the generic oncology drugs market. The market is projected to reach a valuation of $37.08 billion in 2029, growing at a compound annual growth rate (CAGR) of 6.6%. The projected growth during the forecast period can be linked to factors such as increased biosimilar approvals, intensified competition, the implementation of telemedicine and remote care, tailored treatment plans, and pricing pressure. Emergent trends in the forecast period comprise augmented pharmacovigilance, enhanced regulatory streamlining, a stronger focus on combination therapy, precision in generic oncology medications, and broader market access.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12174&type=smp

#Which Factors Are Currently Driving The Growth Of The Generic Oncology Drugs Market?

The projected increase in the number of cancer patients is set to stimulate the expansion of the generic oncology drugs market. Cancer, a disease characterized by the unchecked growth of cells influencing various organs, is a leading cause of global morbidity and mortality. Affordable generic oncology drugs play a vital part in cancer treatment, enhancing access to key therapies, fostering market competitiveness, and cutting medical costs. For instance, data from the National Cancer Institute (NCI), a government agency in the U.S., revealed that about 5.4% of the population, or 18.1 million people, were recovering from cancer in January 2022. Furthermore, 623,405 individuals were grappling with metastatic cancer, including breast, prostate, lung, colorectal, or bladder cancer, or metastatic melanoma in 2022, with predictions of this figure shooting up to 693,452 by 2025. Hence, the anticipated increase in cancer patients is fueling the growth of the generic oncology drugs market.

How Is The Global Generic Oncology Drugs Market Structured In Terms Of Segments?

The generic oncology drugs market covered in this report is segmented –

1) By Molecule Type: Large Molecule, Small Molecule

2) By Route Of Administration: Oral, Parenteral

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacies, Managed Care Institutions

Subsegments:

1) By Large Molecule: Monoclonal Antibodies, Biologics, Biosimilars

2) By Small Molecule: Chemotherapeutics, Targeted Therapy Agents, Hormonal Therapy Drugs

What Trends Are Currently Influencing Growth In The Generic Oncology Drugs Market?

The emergence of unique formulations is an apparent trend in the generic oncology drugs market. Leading businesses in this field are prioritizing the creation of innovative drug delivery systems, modified release structures, and alternative dose forms in order to increase patient adherence and retain their standing within the market. For example, in January 2023, MSN Laboratories Private Limited, a generic drug-focused pharmacy firm based in India, introduced Palborest – the first generic version of the Palbociclib tablets for advanced breast cancer therapy worldwide. Palborest serves as a wallet-friendly alternative to the original tablet while keeping up the bioequivalence. The tablet-based dosage is considered more advantageous compared to capsules as it can be ingested alongside or without food, and leveraged with proton pump inhibitors or antacids. Moreover, being devoid of lactose and gelatin enhances the medication’s effectiveness.

Who Are The Main Participants Shaping The Generic Oncology Drugs Market Landscape?

Major companies operating in the generic oncology drugs market include Pfizer Inc., AbbVie, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories, Fresenius Kabi AG, GlaxoSmithKline PLC, Eli Lilly and Company, Merck & Co. Inc., Baxter International Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Inc., Hikma Pharmaceuticals, Endo Pharmaceuticals Inc., Aspen Pharmacare Holdings Limited, Lupin Limited, Towa Pharmaceutical Co Ltd, Torrent Pharmaceuticals Ltd., Cadila Healthcare Ltd., Accord Healthcare

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/generic-oncology-drugs-global-market-report

Which Region Currently Holds The Largest Share In The Generic Oncology Drugs Market?

North America was the largest region in the generic oncology drugs market in 2024. The regions covered in the generic oncology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12174&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model